ArticleHepatology (Baltimore, Md.)2020

Letter to the Editor: Could Butyrate Be Incorporated With Farnesoid X Receptor Agonist Cilofexor to Enhance Primary Sclerosing Cholangitis Treatment?

Jiezhong Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.